Bachrodt Amy - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Bachrodt Amy
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2026-01-22
Sale
2026-01-26
4:10 pm
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
5,000$45.52$227,61221,320
(Direct)
View
2026-01-02
Sale
2026-01-06
4:30 pm
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
5,000$39.15$195,75418,325
(Direct)
View
2025-12-29
Sale
2025-12-31
4:20 pm
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
15,000$40.41$606,17341,777
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2026-01-22
Exercise
2026-01-26
4:10 pm
N/A
2031-03-03
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
5,000$021,320
(Direct)
View
2026-01-22
Exercise
2026-01-26
4:10 pm
N/A
N/A
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
5,000$10.4221,320
(Direct)
View
2026-01-02
Exercise
2026-01-06
4:30 pm
N/A
2032-10-26
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
5,000$018,325
(Direct)
View
2026-01-02
Exercise
2026-01-06
4:30 pm
N/A
N/A
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
5,000$10.4218,325
(Direct)
View
2025-12-29
Exercise
2025-12-31
4:20 pm
N/A
2031-02-01
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
15,000$041,777
(Direct)
View
2025-12-29
Exercise
2025-12-31
4:20 pm
N/A
N/A
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
15,000$10.4241,777
(Direct)
View
2025-09-22
Option Award
2025-09-24
4:23 pm
N/A
N/A
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
22,000$022,000
(Direct)
View

Ownership
2025-01-30
4:21 pm
N/A
N/A
Maze Therapeutics Inc.MAZEBachrodt Amy
SVP, Finance
0$0123,874
(Direct)
View